Occupational Therapists in Weymouth, MA Accepting Medicare
68 Occupational Therapists found. Showing 61 - 68
 South Shore Therapies Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 163 Libbey Industrial Pkwy, Suite 302, Weymouth, MA 02189 Phone: 781-335-6663 Fax: 781-335-6686 |
 Julie A Garber, OTR/L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 574 Main St, Weymouth, MA 02190 Phone: 781-331-2533 Fax: 781-340-1337 |
Diana Capellupo, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 574 Main St, Weymouth, MA 02190 Phone: 781-331-2533 |
Jessica F Collins, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 163 Libbey Industrial Pkwy Ste 302, Weymouth, MA 02189 Phone: 781-335-6663 |
Karen Connell Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 163 Libbey Industrial Parkway, Suite 302, Weymouth, MA 02189 Phone: 781-335-6663 |
Ms. Jennifer Donnelly Hughes, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 65 Webster St Apt 102, Weymouth, MA 02190 Phone: 339-206-1404 |
Stacey Szklut Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 163 Libbey Industrial Pkwy, Suite 302, Weymouth, MA 02189 Phone: 781-335-6663 |
Irene Kershaw Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 163 Libbey Industrial Pkwy, Suite 302, Weymouth, MA 02189 Phone: 781-335-6663 |
News Archive
Stanford researchers develop novel technique for mapping diversity of gut bacteria
A collaboration between computer scientists and geneticists at Stanford University has produced a novel technique for mapping the diversity of bacteria living in the human gut.
Amgen's Vectibix (panitumumab) receives EC approval for treatment patients with WT RAS mCRC
Amgen today announced that the European Commission approved a new use of Vectibix (panitumumab) as first-line treatment in combination with FOLFIRI for the treatment of adult patients with wild-type (WT) RAS metastatic colorectal cancer (mCRC).
RapifleX MALDI PharmaPlus Solution for uHTS launched by Bruker
At the 64th ASMS Conference, Bruker announces the launch of the new rapifleX™ MALDI PharmaPulse™ (MPP) solution. It is the latest addition to Bruker's portfolio of innovative products designed to assist pharmaceutical, biotech and CRO customers to accelerate drug discovery, and rapifleX MPP can dramatically lower the cost of ultra-high throughput screening (uHTS) with further improved results.
Study examines how masks disrupt facial perception
The identification of people wearing masks has often presented a unique challenge during the pandemic. A new study by researchers from Ben-Gurion University of the Negev (BGU) in Israel and York University in Canada reveals the impact of this predicament and its potentially significant repercussions.
› Verified 8 days ago
Occupational Therapists
Physical Therapists
Speech-Language Pathologists
Chiropractors
Optometrists
Podiatrists
Audiologists